WAY-126241

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWAY-126241
Drug Alias NameWAY-126241
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene D4 antagonistsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseLeukotriene D4
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWyeth-Ayerst International Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth-Ayerst International Llc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A